Less than 2% of cases were reported hyperglycemia in linsitinib trials, which means it is safe for glucose management in diabetic pancreatic cancer patients
If your tirzepatide suddenly seems less effective, with reduced appetite suppression , less weight loss progress , or return of hunger between doses, and nothing else in your protocol has changed, degraded medication is one possible explanation
Additionally, these medications require strict refrigeration to maintain their effectiveness, and improper storage can render them useless or worse, unsafe
An editorial that accompanied the Nov
Takenaka M., Sato N., Asakawa H., Wen X., Murata M., and Homma S